Merck expects legal challenges over two ancillary patents for Keytruda that expire in 2029. This anticipated litigation signals significant legal costs and uncertainty as the company attempts to prolong its exclusivity for its top-selling drug beyond the main 2028 patent expiration.
Filing excerpt
The compound patent family contains two additional patents that expire in 2029 due to patent term adjustment resulting from patent office delay... While these patents may provide additional protection, the Company expects that they will be the subject of litigation in the future.
What this signalsFilings often name leadership changes, deals and spending plans.
Regions named
sec-10klitigationMaterialGet every 10-K signal for Merck and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Merck this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/9e6a39cd-82f4-415f-b8b4-8695f1d59c95 returns this record as JSON. POST /v1/companies/enrich returns every signal for merck.com.
{
"signal_id": "9e6a39cd-82f4-415f-b8b4-8695f1d59c95",
"signal_type": "sec-10k",
"signal_subtype": "litigationMaterial",
"detected_at": "2026-03-03T05:49:01.153+00:00",
"company": {
"name": "Merck",
"domain": "merck.com"
},
"data": {
"detail": "Merck expects legal challenges over two ancillary patents for Keytruda that expire in 2029. This anticipated litigation signals significant legal costs and uncertainty as the company attempts to prolong its exclusivity for its top-selling drug beyond the main 2028 patent expiration.",
"metrics": {
"timeframe": "multi_year"
},
"summary": "Company anticipates future litigation over Keytruda patents to defend market exclusivity.",
"excerpts": "The compound patent family contains two additional patents that expire in 2029 due to patent term adjustment resulting from patent office delay... While these patents may provide additional protection, the Company expects that they will be the subject of litigation in the future.",
"relevance": 0.9,
"sentiment": "negative",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/310158/000031015826000063/mrk-20251231.htm",
"filing_date": "2026-02-24",
"filing_year": 2026,
"fiscal_year_end": "12/31",
"sales_relevance": "Legal tech opportunity",
"signal_category": "risk",
"regions_mentioned": [
"U.S."
]
}
}
curl https://signals.autobound.ai/v1/signals/9e6a39cd-82f4-415f-b8b4-8695f1d59c95 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"merck.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.